News

Samsung Biologics announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy, furthering the company’s track record as a premiere CDO service provider in the global market. In...

The New Zealand Government has granted formal approval for use of Pfizer and BioNTech’s Covid-19 vaccine as a critical step to ensure the vaccine is safe and effective. Last week, the New Zealand Medicines and Medical Devices Safety Authority, Medsafe,...

Pfizer announced a partnership with IDA Foundation, an independent social enterprise providing essential medicines to low-and middle-income countries, to provide equitable access to quality cancer treatments in almost 70 developing countries across Latin America, Asia, Africa and the Western...

PHARMASEAL, a provider of clinical trial management and governance solutions, announced today that it has secured its first Medical Device customer – an award-winning US-based company providing ultrasound technology. The Engility® Trial Management Platform was chosen following review of several...

Raremark®, the global healthtech company specializing in rare disease, has today announced the appointment of Dale Jessop as Chief Technical Officer. Jessop brings a wealth of expertise and two decades worth of experience to the business, having worked for companies...

AbbVie and Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome editing biotechnology company, announced that they have entered into a collaboration and license agreement for the research and development of chimeric antigen receptor (CAR)-T cell therapeutics. Although allogeneic, "off-the-shelf"...

Global contract development and manufacturing organisation (CDMO), Recipharm, has successfully extended its manufacturing license to include immunology products, allowing them to cater for customers’ vaccine products at clinical and commercial scales, in both freeze-dried and liquid forms. The license, which...